Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7096 AL 7110

Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease

Ganguly G, Chakrabarti S, Chatterjee U, Saso L.

Drug Des Devel Ther. 2017 Mar 16;11:797-810. doi: 10.2147/DDDT.S130514. eCollection 2017.

Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease

Braidy N, Behzad S, Habtemariam S, Ahmed T, Daglia M, Nabavi SM, Sobarzo-Sanchez E, Nabavi SF.

CNS Neurol Disord Drug Targets. 2017;16(4):387-397. doi: 10.2174/1871527316666170328113309.

Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade

Chiti F, Dobson CM.

Annu Rev Biochem. 2017 Jun 20;86:27-68. doi: 10.1146/annurev-biochem-061516-045115. Epub 2017 May 12.

Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla

Markowicz-Piasecka M, Sikora J, Szydłowska A, Skupień A, Mikiciuk-Olasik E, Huttunen KM.

Pharm Res. 2017 Dec;34(12):2614-2627. doi: 10.1007/s11095-017-2199-y. Epub 2017 Jun 6.

Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease

Li Y, Zhao J, Hölscher C.

CNS Drugs. 2017 Aug;31(8):639-652. doi: 10.1007/s40263-017-0451-y.

Recent Advances on the Role of Neurogenesis in the Adult Brain: Therapeutic Potential in Parkinson's and Alzheimer's Diseases

Radad K, Moldzio R, Al-Shraim M, Kranner B, Krewenka C, Rausch WD.

CNS Neurol Disord Drug Targets. 2017;16(7):740-748. doi: 10.2174/1871527316666170623094728.

Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs

Lazarevic-Pasti T, Leskovac A, Momic T, Petrovic S, Vasic V.

Curr Med Chem. 2017;24(30):3283-3309. doi: 10.2174/0929867324666170705123509.

Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease

Itoh Y, Voskuhl RR.

PLoS One. 2017 Jul 17;12(7):e0181349. doi: 10.1371/journal.pone.0181349. eCollection 2017.

Dietary Modulation of Oxidative Stress in Alzheimer's Disease

Thapa A, Carroll NJ.

Int J Mol Sci. 2017 Jul 21;18(7):1583. doi: 10.3390/ijms18071583.

Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases

Alam Q, Alam MZ, Sait KHW, Anfinan N, Noorwali AW, Kamal MA, Khan MSA, Haque A.

Curr Drug Metab. 2017;18(9):868-876. doi: 10.2174/1389200218666170728115606.

Iron in neurodegenerative disorders: being in the wrong place at the wrong time?

Apostolakis S, Kypraiou AM.

Rev Neurosci. 2017 Nov 27;28(8):893-911. doi: 10.1515/revneuro-2017-0020.

Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies

Brodowicz J, Przegaliński E, Müller CP, Filip M.

Neurotox Res. 2018 Feb;33(2):474-484. doi: 10.1007/s12640-017-9798-6. Epub 2017 Aug 25.

[Memantine: from the original brand to generics]

Titova NV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):136-143. doi: 10.17116/jnevro2017117101136-143.

Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review

Bansal R, Singh R.

Med Res Rev. 2018 Jul;38(4):1126-1158. doi: 10.1002/med.21458. Epub 2017 Jul 11.

Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease

Ji C, Xue GF, Li G, Li D, Hölscher C.

Rev Neurosci. 2016 Jan;27(1):61-70. doi: 10.1515/revneuro-2015-0021.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias